255 related articles for article (PubMed ID: 22271903)
1. Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.
Sandes AF; Yamamoto M; Matarraz S; Chauffaille Mde L; Quijano S; López A; Oguro T; Kimura EY; Orfao A
Haematologica; 2012 Jun; 97(6):895-902. PubMed ID: 22271903
[TBL] [Abstract][Full Text] [Related]
2. Abnormal platelet phenotypes in patients with myelodysplastic syndromes.
Liu J; Niu H; Yue L; Lv Q; Yang L; Liu C; Jiang H; Xing L; Shao Z; Wang H
Int J Lab Hematol; 2020 Aug; 42(4):371-379. PubMed ID: 32202052
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
[TBL] [Abstract][Full Text] [Related]
4. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study.
Wu YF; Gu MH; Liu CZ; Huang WH; Chu SC; Wang TF
PLoS One; 2022; 17(11):e0278040. PubMed ID: 36409726
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome.
Stetler-Stevenson M; Arthur DC; Jabbour N; Xie XY; Molldrem J; Barrett AJ; Venzon D; Rick ME
Blood; 2001 Aug; 98(4):979-87. PubMed ID: 11493442
[TBL] [Abstract][Full Text] [Related]
6. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets.
Debili N; Wendling F; Cosman D; Titeux M; Florindo C; Dusanter-Fourt I; Schooley K; Methia N; Charon M; Nador R
Blood; 1995 Jan; 85(2):391-401. PubMed ID: 7529061
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.
Jaimes Y; Gras C; Goudeva L; Buchholz S; Eiz-Vesper B; Seltsam A; Immenschuh S; Blasczyk R; Figueiredo C
J Thromb Haemost; 2012 Jun; 10(6):1100-8. PubMed ID: 22448926
[TBL] [Abstract][Full Text] [Related]
8. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic clustering of myelodysplastic syndromes.
Maynadié M; Picard F; Husson B; Chatelain B; Cornet Y; Le Roux G; Campos L; Dromelet A; Lepelley P; Jouault H; Imbert M; Rosenwadj M; Vergé V; Bissières P; Raphaël M; Béné MC; Feuillard J;
Blood; 2002 Oct; 100(7):2349-56. PubMed ID: 12239142
[TBL] [Abstract][Full Text] [Related]
10. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.
Della Porta MG; Picone C; Pascutto C; Malcovati L; Tamura H; Handa H; Czader M; Freeman S; Vyas P; Porwit A; Saft L; Westers TM; Alhan C; Cali C; van de Loosdrecht AA; Ogata K
Haematologica; 2012 Aug; 97(8):1209-17. PubMed ID: 22315489
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
Falco P; Levis A; Stacchini A; Ciriello MM; Geuna M; Notari P; Omedè P; Pautasso M; Prato G; Strola G; Gioia D; Bonferroni M; Cametti G; Ferrero D; Freilone R; Gaidano G; Marinone C; Marmont F; Pollio B; Salvi F; Saglio G; Girotto M;
Eur J Haematol; 2011 Nov; 87(5):409-18. PubMed ID: 21711395
[TBL] [Abstract][Full Text] [Related]
12. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
van Velzen JF; Laros-van Gorkom BA; Pop GA; van Heerde WL
Thromb Res; 2012 Jul; 130(1):92-8. PubMed ID: 22424855
[TBL] [Abstract][Full Text] [Related]
13. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
Hofmann WK; Kalina U; Wagner S; Seipelt G; Ries C; Hoelzer D; Ottmann OG
Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
[TBL] [Abstract][Full Text] [Related]
14. Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients.
Houwerzijl EJ; Blom NR; van der Want JJ; Louwes H; Esselink MT; Smit JW; Vellenga E; de Wolf JT
Blood; 2005 May; 105(9):3472-9. PubMed ID: 15542580
[TBL] [Abstract][Full Text] [Related]
15. [The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].
Czyz A; Dworacki G; Komarnicki M
Postepy Hig Med Dosw (Online); 2008 Jul; 62():354-63. PubMed ID: 18688206
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cells.
Qiao X; Loudovaris M; Unverzagt K; Walker DE; Smith SL; Martinson J; Schilling M; Lee W; Williams SF; Van Epps DE; Cohen I; Bender JG
Cytometry; 1996 Mar; 23(3):250-9. PubMed ID: 8974870
[TBL] [Abstract][Full Text] [Related]
17. Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia.
Blair TA; Michelson AD; Frelinger AL
Sci Rep; 2018 Jul; 8(1):10300. PubMed ID: 29985398
[TBL] [Abstract][Full Text] [Related]
18. Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
Strapatsas J; Barbulescu EC; Lauseker M; Kaivers J; Hildebrandt B; Nachtkamp K; Strupp C; Rudelius M; Haas R; Germing U
Ann Hematol; 2021 Oct; 100(10):2575-2584. PubMed ID: 34324021
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes.
Gardikas N; Vikentiou M; Konsta E; Kontos CK; Papageorgiou SG; Spathis A; Bazani E; Bouchla A; Kapsimali V; Psarra K; Foukas P; Dimitriadis G; Pappa V
Cytometry B Clin Cytom; 2019 Jan; 96(1):73-82. PubMed ID: 30334347
[TBL] [Abstract][Full Text] [Related]
20. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
van de Loosdrecht AA; Alhan C; Béné MC; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Homburg CH; Ireland R; Jansen JH; Kern W; Malcovati L; Te Marvelde JG; Mufti GJ; Ogata K; Orfao A; Ossenkoppele GJ; Porwit A; Preijers FW; Richards SJ; Schuurhuis GJ; Subirá D; Valent P; van der Velden VH; Vyas P; Westra AH; de Witte TM; Wells DA; Loken MR; Westers TM
Haematologica; 2009 Aug; 94(8):1124-34. PubMed ID: 19546437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]